Category Archives: ALS Treatment

D-Pharm mulls buying Thrombotech

Thrombotech's peptide, THR-18 for the treatment of thrombolytic strokes, is undergoing a Phase IIa clinical safety and efficacy trial. Continue reading

Posted in ALS Treatment | Tagged , , , , , , | Comments Off

Joost happy with treatment

Former Springbok Joost van der Westhuizen said treatment for his motor neuron disease appeared to be working well. Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , | Comments Off

Stars Celebrate Muhammad Ali's 70th Birthday in Las Vegas at Keep Memory Alive's Annual "Power of Love Gala" Fundraiser

LAS VEGAS, Feb. 19, 2012 /PRNewswire/ – Keep Memory Alive's 16th annual Power of Love Gala on Saturday, Feb. 18, at MGM Grand Garden Arena in Las Vegas brought out some of the biggest names in sports … Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , | Comments Off

Executive finds new strength in disease's legacy

Neil Alexander has been given a bad break. In June, the 46-year-old husband and father of two young children from O'Hara was diagnosed with amyotrophic lateral sclerosis. ALS is a neurodegenerative disease that leads to the “glass coffin.” The mind remains intact, but a person with ALS loses use of his hands, arms and legs, then has trouble swallowing and breathing Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , | Comments Off

ALS Therapy nonprofit launches first Phase 2 drug trial

The ALS Therapy Development Institute (ALS TDI), a Cambridge-based nonprofit formed in 1999, said it is starting a Phase 2 trial of TDI 132, a candidate to treat Lou Gehrig’s disease (amyotrophic lateral sclerosis or ALS). Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , , | Comments Off

The ALS Therapy Development Institute to Launch Phase II Clinical Trial of TDI 132 in ALS Patients

CAMBRIDGE, Mass., Feb. 14, 2012 /PRNewswire-USNewswire/ — The ALS Therapy Development Institute (ALS TDI) will launch a Phase II clinical trial on TDI 132 (aka: fingolimod/Gilenya(R)) as a potential treatment for ALS (Lou Gehrig's disease). Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , | Comments Off

Peoria Fire Department Upgrades Hope To Save Lives

PEORIA – The Peoria Fire Department hopes some major upgrades will help save lives. Continue reading

Posted in ALS Treatment | Tagged , , , , , , | Comments Off

Scientists Find New Treatment for Kidney Disease

Two researchers at UCSB, associate professor Thomas Weimbs and graduate student Jeffery Talbot, recently published a study in the Proceedings of the National Academy of Sciences on a new possible drug target for the treatment of autosomal dominant polycystic kidney disease. Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , | Comments Off

Researchers find additional benefits of cord blood cells in mice modeling ALS

Repeated, low-dose injections of mononuclear cells derived from human umbilical cord blood (MNC hUCB, tradename: U-CORD-CELL) have been found effective in protecting motor neuron cells, delaying disease progression and increasing lifespan for mice modeling amyotrophic lateral sclerosis, or ALS, also referred to as Lou Gehrig's disease, report University of South Florida researchers and … Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , | Comments Off

USF and Saneron researchers find additional benefits of cord blood cells in mice modeling ALS

( University of South Florida (USF Health) ) Repeated, low-dose injections of mononuclear cells derived from human umbilical cord blood were effective in protecting motor neuron cells, delaying disease progression and increasing lifespan for mice modeling amyotrophic lateral sclerosis, or ALS, also referred to as Lou Gehrig's disease. Continue reading

Posted in ALS Treatment | Tagged , , , , , , , , , , , | Comments Off